Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 2
1988 1
1990 1
1993 2
1994 2
1995 1
1997 1
1998 11
1999 1
2000 1
2001 1
2003 5
2004 2
2009 1
2011 4
2012 4
2013 3
2014 4
2016 1
2017 1
2019 2
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
Treatment of autoimmune myasthenia gravis.
Richman DP, Agius MA. Richman DP, et al. Among authors: agius ma. Neurology. 2003 Dec 23;61(12):1652-61. doi: 10.1212/01.wnl.0000098887.24618.a0. Neurology. 2003. PMID: 14694025 Review.
Acquired myasthenia gravis. Immunopathology.
Richman DP, Agius MA. Richman DP, et al. Among authors: agius ma. Neurol Clin. 1994 May;12(2):273-84. Neurol Clin. 1994. PMID: 8041342 Review.
Animal models of antimuscle-specific kinase myasthenia.
Richman DP, Nishi K, Ferns MJ, Schnier J, Pytel P, Maselli RA, Agius MA. Richman DP, et al. Among authors: agius ma. Ann N Y Acad Sci. 2012 Dec;1274:140-7. doi: 10.1111/j.1749-6632.2012.06782.x. Ann N Y Acad Sci. 2012. PMID: 23252909 Free PMC article.
Multiple sclerosis.
Agius MA. Agius MA. West J Med. 1995 Nov;163(5):473. West J Med. 1995. PMID: 8533414 Free PMC article. No abstract available.
Immune thrombocytopenia in alemtuzumab-treated MS patients: Incidence, detection, and management.
Cuker A, Bass AD, Nadj C, Agius MA, Steingo B, Selmaj KW, Thoits T, Guerreiro A, Van Wijmeersch B, Ziemssen T, Meuth SG, LaGanke CC, Thangavelu K, Rodriguez CE, Baker DP, Margolin DH, Jannsens A. Cuker A, et al. Among authors: agius ma. Mult Scler. 2020 Jan;26(1):48-56. doi: 10.1177/1352458518816612. Epub 2019 Feb 20. Mult Scler. 2020. PMID: 30785358 Free PMC article. Clinical Trial.
Antibody effector mechanisms in myasthenia gravis. The complement hypothesis.
Richman DP, Agius MA, Kirvan CA, Gomez CM, Fairclough RH, Dupont BL, Maselli RA. Richman DP, et al. Among authors: agius ma. Ann N Y Acad Sci. 1998 May 13;841:450-65. doi: 10.1111/j.1749-6632.1998.tb10962.x. Ann N Y Acad Sci. 1998. PMID: 9668274 Review. No abstract available.
Myasthenia gravis: pathogenesis and treatment.
Richman DP, Agius MA. Richman DP, et al. Among authors: agius ma. Semin Neurol. 1994 Jun;14(2):106-10. doi: 10.1055/s-2008-1041066. Semin Neurol. 1994. PMID: 7984824 Review.
Three forms of immune myasthenia.
Agius MA, Richman DP, Fairclough RH, Aarli J, Gilhus NE, Romi F. Agius MA, et al. Ann N Y Acad Sci. 2003 Sep;998:453-6. doi: 10.1196/annals.1254.059. Ann N Y Acad Sci. 2003. PMID: 14592914
48 results